Matrix Metalloproteinase-2 Expression as a Prognostic Marker in Breast Carcinomas
Introduction: Matrix Metalloproteinase-2 (MMP-2) is over expressed in a variety of malignant tumours and their expression and activity are often associated with tumour aggressiveness and a poor prognosis. It serves as a prognostic marker in breast carcinoma regardless of patient age, disease sta...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2021-04-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://www.jcdr.net/articles/PDF/14835/47478_CE[Ra1]_F(KM)_PF1(AG_SL)_PFA(Pr_KM)_PN(KM).pdf |